What is Distalgesic (paracetamol/dihydrocodeine) and what are its dosing guidelines, contraindications, and precautions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Distalgesic: Important Safety Warning

Distalgesic is a discontinued combination analgesic containing dextropropoxyphene (propoxyphene) 32.5 mg and paracetamol (acetaminophen) 325 mg per tablet that was withdrawn from most markets due to serious safety concerns, including rapid-onset fatal overdoses and cardiac toxicity.

What Distalgesic Was

Distalgesic was a WHO Step II analgesic (for mild to moderate pain) combining:

  • Dextropropoxyphene hydrochloride 32.5 mg (a weak opioid)
  • Paracetamol 325 mg (a non-opioid analgesic)

Why It Was Withdrawn

Fatal overdose risk: Death characteristically occurred rapidly—as little as 1 hour after ingestion and usually before hospital treatment could be initiated 1. The fatal dose could be as small as 15 tablets or possibly less 1. Convulsions and respiratory failure preceded death, with toxicity significantly increased by alcohol 1.

Addiction liability: Evidence suggested liability to dependence or even addiction with dextropropoxyphene 1.

Current Guideline-Recommended Alternatives

For mild to moderate pain (WHO Step II), current ESMO guidelines recommend 2:

First-Line Combination Therapy

  • Paracetamol 500-1000 mg (maximum 4-6 g daily) PLUS
  • Weak opioids in combination:
    • Codeine 30-60 mg every 4-6 hours (maximum 240 mg daily) 3, 4
    • Dihydrocodeine 60-120 mg controlled-release twice daily (maximum 240 mg daily) 3, 5
    • Tramadol 50-100 mg every 4-6 hours (maximum 400 mg daily) 3, 5

Alternative Approach

  • Low doses of strong opioids (morphine, oxycodone) in combination with non-opioid analgesics 2

Specific Dosing for Oxycodone-Acetaminophen

  • Oxycodone 5-15 mg with acetaminophen every 4-6 hours 4
  • Note: Acetaminophen component now limited to ≤325 mg per tablet 4

Evidence-Based Comparison

Dihydrocodeine showed superior efficacy to dextropropoxyphene/paracetamol combinations: After 2 weeks' treatment, controlled-release dihydrocodeine provided statistically significantly less severe pain on passive movement (p=0.02) compared to dextropropoxyphene/paracetamol, with no difference in side-effects by study end 6. Dihydrocodeine also offers the advantage of twice-daily versus 3-4 times daily dosing 6.

Critical Prescribing Principles

For chronic pain 2:

  • Prescribe analgesics on a regular schedule, not "as required"
  • Provide rescue doses (10-15% of total daily dose) for breakthrough pain
  • If >4 breakthrough doses needed daily, increase baseline therapy

Mandatory co-prescribing with opioids 2:

  • Laxatives must be routinely prescribed for prophylaxis and management of opioid-induced constipation
  • Antiemetics (metoclopramide, antidopaminergic drugs) for opioid-related nausea/vomiting

Special Populations

Renal impairment: All opioids should be used with caution at reduced doses and frequency 2. For chronic kidney disease stages 4-5 (eGFR <30 mL/min), fentanyl and buprenorphine (transdermal or IV) are the safest choices 2.

Paracetamol maximum dosing: 4-6 g daily in normal patients 3, 7, 5; dose reduction recommended in liver disease or malnourished patients 8.

Common Pitfall to Avoid

Do not use dextropropoxyphene/propoxyphene if somehow still available—it has been removed from guidelines due to unfavorable risk-benefit profile, particularly the rapid-onset fatal overdose risk that occurs before medical intervention is possible 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.